Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Nextcure Inc (NXTC)

Nextcure Inc (NXTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
NextCure, Inc. Reports Promising Preclinical Data for NC605 in Osteogenesis Imperfecta Treatment Quiver Quantitative, Inc. - Tue Nov 19, 5:20PM CST

NextCure presented promising preclinical data on NC605, an antibody that enhances bone quality in Osteogenesis Imperfecta.Quiver AI SummaryNextCure, Inc. has announced promising preclinical data showcasing...

NXTC : 1.3100 (+1.55%)
Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta GlobeNewswire - Tue Nov 19, 7:05AM CST

NXTC : 1.3100 (+1.55%)
NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results GlobeNewswire - Thu Nov 7, 3:05PM CST

NXTC : 1.3100 (+1.55%)
NextCure Reports Preclinical Data for LNCB74 and Additional Clinical Biomarker Data for NC410 Combo at Society for Immunotherapy of Cancer Annual Meeting GlobeNewswire - Tue Nov 5, 3:05PM CST

NXTC : 1.3100 (+1.55%)
NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting GlobeNewswire - Fri Oct 4, 8:05AM CDT

NXTC : 1.3100 (+1.55%)
Jon Soderstrom Joins Wilson Sonsini as Chief Licensing Advisor Business Wire - Mon Nov 28, 2022

Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, announced today that Jon Soderstrom is joining the firm as its chief...

ACHN : 0.7912 (-21.66%)
ARVN : 21.64 (-6.68%)
NXTC : 1.3100 (+1.55%)
BHVN : 46.30 (+1.96%)
INZY : 2.81 (-2.43%)
NextCure Presented NC410 Data at the Extracellular Matrix (ECM) Pharmacology Congress in Europe on Overcoming Clinical Limitations to Immunotherapy Through Remodeling Tumor ECM Globe Newswire - Mon Jun 27, 2022

BELTSVILLE, Md., June 27, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and...

NXTC : 1.3100 (+1.55%)
NextCure Presented NC410 Data at the Extracellular Matrix (ECM) Pharmacology Congress in Europe on Overcoming Clinical Limitations to Immunotherapy Through Remodeling Tumor ECM Globe Newswire - Mon Jun 27, 2022

BELTSVILLE, Md., June 27, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and...

NXTC : 1.3100 (+1.55%)
Dr. Brahm Segal appointed to NextCure Scientific Advisory Board; NextCure and Roswell Park Shared Nonclinical Data on the Impact of NC410 Blockade on Neutrophil-mediated T Cell Suppression at the 24th Translational Research Cancer Centers Consortium Globe Newswire - Wed Jun 22, 2022

BELTSVILLE, Md., June 22, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and...

NXTC : 1.3100 (+1.55%)
NextCure to Present at the JMP Securities Life Sciences Conference Globe Newswire - Wed Jun 8, 2022

BELTSVILLE, Md., June 08, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and...

NXTC : 1.3100 (+1.55%)

Barchart Exclusives

Has the Global Wheat Market Changed? Barchart - Tue Nov 19, 6:49PM CST
The spotlight has turned to global wheat markets this week as the situation in the Black Sea region of the world intensifies. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot